BRIEF-UNITY Biotechnology Estimates $3.7 Million Expenses For Reduction In Force

Reuters
05-05
BRIEF-UNITY Biotechnology Estimates $3.7 Million Expenses For Reduction In Force

May 5 (Reuters) - UNITY Biotechnology Inc UBX.O:

  • UNITY BIOTECHNOLOGY INC - COMPANY ESTIMATES $3.7 MILLION CASH EXPENSES FOR REDUCTION IN FORCE - SEC FILING

  • UNITY BIOTECHNOLOGY INC - REDUCTION IN FORCE EXPECTED TO BE COMPLETED BY MAY 15, 2025 - SEC FILING

  • UNITY BIOTECHNOLOGY INC - CEO ANIRVAN GHOSH, CFO LYNNE SULLIVAN, AND ALEXANDER NGUYEN TO TERMINATE EMPLOYMENT - SEC FILING

Source text: [ID:n0000950170-25-063167]

Further company coverage: UBX.O

((Reuters.Briefs@thomsonreuters.com;))

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10